Finance

Lists
300482:SHE
Guangzhou Wondfo Biotech Co Ltd
CN¥15.76
-0.57%
(-0.090) 1D
Oct 16, 3:04:37 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300482...
Open
CN¥16.00
High
CN¥16.38
Low
CN¥15.64
Mkt. cap
7.62B
Avg. vol.
4.48M
Volume
5.79M
Dividend
1.40%
Quarterly dividend
CN¥0.06
Ex-dividend date
Jun 2, 2026
52-wk high
CN¥26.29
52-wk low
CN¥15.40
EPS
-CN¥0.25
Shares outstanding
468.15M
No. of employees
2K
Open
CN¥16.00
High
CN¥16.38
Low
CN¥15.64
Mkt. cap
7.62B
Avg. vol.
4.48M
Volume
5.79M
Dividend
1.40%
Quarterly dividend
CN¥0.06
Ex-dividend date
Jun 2, 2026
52-wk high
CN¥26.29
52-wk low
CN¥15.40
EPS
-CN¥0.25
Shares outstanding
468.15M
No. of employees
2K
News stories
From web sources and news partners
About Guangzhou Wondfo Biotech Co Ltd
CEO-
Employees2.44K
FoundedNov 13, 1992
Headquarters-
SectorMedical device
Websitewondfo.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
444.52M
396.65M
581.74M
456.76M
Cost of goods sold
212.69M
238.24M
213.83M
164.92M
Cost of revenue
212.69M
238.24M
213.83M
164.92M
Research and development expenses
90.88M
71.60M
73.65M
64.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220.15M
327.80M
177.81M
179.63M
Operating expense
310.42M
396.37M
267.63M
247.66M
Total operating expenses
523.11M
634.61M
481.47M
412.58M
Operating income
-78.59M
-237.96M
100.28M
44.18M
Other non operating income
-9.71M
7.75M
-13.32M
11.58M
EBT including unusual items
-78.16M
-241.31M
97.18M
43.38M
EBT excluding unusual items
-87.55M
-224.63M
84.28M
32.84M
Income tax expense
-14.38M
-45.22M
11.06M
4.34M
Effective tax rate
18.40%
18.74%
11.38%
10.01%
Other operating expenses
2.04M
3.96M
8.28M
7.46M
Net income
-55.46M
-196.76M
84.40M
38.12M
Net profit margin
-12.48%
-49.61%
14.51%
8.35%
Earnings per share
-
-
-
-
Interest and investment income
6.67M
28.80M
4.76M
6.83M
Interest expense
-8.89M
-7.00M
-7.45M
-7.23M
Net interest expenses
-2.22M
21.80M
-2.68M
-402.25K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.98M
-181.85M
156.39M
98.84M
Gain or loss from assets sale
-2.09K
-318.79K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps